Evaluation of analgesic effect of diluted lidocaine spray in reducing pain caused by burning debridement in burning patients admitted to Ali-ebn Abitaleb Hospital in Zahedan between 2022 and 2023
- Conditions
- Pain after a burn.Acute pain due to traumaG89.11
- Registration Number
- IRCT20231126060194N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
1. Informed and free consent to participate in the study 2. Burn severity above 10% 3. Patients admitted to the burn department of Ali Bin Abi Talib Zahedan Hospital
1. Impaired level of consciousness (GCS < 15) 2. Hemodynamic disturbance during drug injection (SBP = 90 and PR = 60 and RR = 8 and = 90% (O2) and in patients with blood pressure (SBP = 180) or (SBP = 100) ) 3. Use of drugs or alcohol or sedatives or pain relievers in the last 48 hours 4. History of taking MAOI, TCA, SSRI, phenothiazines or sleeping pills 5. Suffering from chronic diseases (congenital or acquired heart diseases, heart failure chronic liver disease, biliary tract diseases, kidney failure and chronic lung disease) according to history and clinical examination 6. Asthma according to history and clinical examination 7. Allergy to lidocaine and pethidine 8. Weight more than 100 kg 9. Lack of consent to enter the study 10. Patient's lack of cooperation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the amount of pain reported by the patient (pain measured by visual observation). Timepoint: The pain level will be asked and recorded at times 0, 5, 10, 20, 30, and 60 minutes. Method of measurement: VAS criterion.
- Secondary Outcome Measures
Name Time Method Analgesia onset time in patients receiving lidocaine and IV pethidine. Timepoint: Time after starting to receive lidocaine (in minutes). Method of measurement: Time in minutes.